LENSAR INC (LNSR) Stock Price & Overview
NASDAQ:LNSR • US52634L1089
Current stock price
The current stock price of LNSR is 5.14 USD. Today LNSR is down by -2.28%. In the past month the price decreased by -5.73%. In the past year, price decreased by -62.19%.
LNSR Key Statistics
- Market Cap
- 62.194M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.90
- Dividend Yield
- N/A
LNSR Stock Performance
LNSR Stock Chart
LNSR Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to LNSR. When comparing the yearly performance of all stocks, LNSR is a bad performer in the overall market: 96.82% of all stocks are doing better.
LNSR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to LNSR. LNSR has a bad profitability rating. Also its financial health evaluation is rather negative.
LNSR Earnings
On March 31, 2026 LNSR reported an EPS of -0.12 and a revenue of 16.02M. The company missed EPS expectations (-68.07% surprise) and missed revenue expectations (-22.61% surprise).
LNSR Forecast & Estimates
7 analysts have analysed LNSR and the average price target is 8.67 USD. This implies a price increase of 68.68% is expected in the next year compared to the current price of 5.14.
For the next year, analysts expect an EPS growth of 81.36% and a revenue growth 0.56% for LNSR
LNSR Groups
Sector & Classification
LNSR Financial Highlights
Over the last trailing twelve months LNSR reported a non-GAAP Earnings per Share(EPS) of -2.9. The EPS decreased by -6.62% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -47.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LNSR Ownership
LNSR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 40.73 | 170.062B | ||
| ABT | ABBOTT LABORATORIES | 14.66 | 160.7B | ||
| SYK | STRYKER CORP | 21.6 | 126.249B | ||
| BSX | BOSTON SCIENTIFIC CORP | 16.09 | 97.627B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.85 | 45.962B | ||
| IDXX | IDEXX LABORATORIES INC | 37.71 | 44.549B | ||
| BDX | BECTON DICKINSON AND CO | 11.31 | 44.092B | ||
| RMD | RESMED INC | 17.85 | 31.978B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.38 | 31.89B | ||
| DXCM | DEXCOM INC | 24.04 | 24.131B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.72 | 17.894B | ||
| PODD | INSULET CORP | 29.16 | 13.313B | ||
| PEN | PENUMBRA INC | 65.08 | 13.094B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About LNSR
Company Profile
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
Company Info
IPO: 2020-09-21
LENSAR INC
2800 Discovery Drive, Suite 100
Orlando FLORIDA 32826 US
CEO: Nicholas Curtis
Employees: 150
Phone: 18885367271
LENSAR INC / LNSR FAQ
What does LENSAR INC do?
LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. The company is headquartered in Orlando, Florida and currently employs 140 full-time employees. The company went IPO on 2020-09-21. The firm is focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. Its product portfolio includes the LENSAR Laser System (LLS), and the ALLY Robotic Cataract Laser Treatment System (ALLY). The firm has developed its ALLY Robotic Cataract Laser System as a compact, ergonomic system utilizing a fast dual-modality laser and integrating artificial intelligence (AI) into proprietary imaging and software. ALLY is designed to transform cataract surgery by utilizing the Company’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes its proprietary Streamline software technology, designed to guide surgeons to achieve better outcomes.
Can you provide the latest stock price for LENSAR INC?
The current stock price of LNSR is 5.14 USD. The price decreased by -2.28% in the last trading session.
What is the dividend status of LENSAR INC?
LNSR does not pay a dividend.
What is the ChartMill rating of LENSAR INC stock?
LNSR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What do analysts say about LENSAR INC (LNSR) stock?
7 analysts have analysed LNSR and the average price target is 8.67 USD. This implies a price increase of 68.68% is expected in the next year compared to the current price of 5.14.
What is the market capitalization of LNSR stock?
LENSAR INC (LNSR) has a market capitalization of 62.19M USD. This makes LNSR a Micro Cap stock.
When does LENSAR INC (LNSR) report earnings?
LENSAR INC (LNSR) will report earnings on 2026-05-07.